News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tasly Pharmaceutical Buys 100% of TaslyDiyi Pharma


4/22/2013 11:42:23 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

April 22, 2013 -- Tasly Pharmaceutical, a company known mainly for its TCM products, paid 1.5 billion RMB ($240 million) to acquire Jiangsu TaslyDiyi Pharmaceutical, a maker of chemical drugs. TaslyDiyi was 75% owned by Tianjin Tasly Group, Tasly Pharma’s corporate parent. The remaining 25% belonged to Chongshi Ventures. In 2003, Tasly Group and Chongshi Ventures bought Diyi Pharma for 67 million RMB, which means their 10-year holding returned 22 times their initial investment. More details....

Stock Symbol: (SHA: 600535)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES